Holen Sie sich die Stockscreener-App
29.18
1.30%
-0.3851
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Adaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now? - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Stock Up 6.0% but GF Value Says Overvalued -- GF Score: 68/100 - gurufocus.com
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 4.4%Should You Buy? - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at 28.79 USD - Investing.com
NCCN’s Myeloma MRD Update Spotlighting clonoSEQ Could Be A Game Changer For Adaptive Biotechnologies (ADPT) - Yahoo Finance
Adaptive Biotechnologies (ADPT): Can Blood Cancer Guidelines Boost Repeat Testing? - Insider Monkey
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year HighShould You Buy? - MarketBeat
Tidal Investments LLC Takes $855,000 Position in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies CPO Francis Lo sells $3.2m in stock - Investing.com
Adaptive Biotechnologies CPO Francis Lo sells $3.2m in stock By Investing.com - Investing.com Canada
Adaptive Biotechnologies (ADPT) HR chief sells over 100,000 shares under preset plan - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Key Financial Ratios – Valuation, Profitability & More - Value Research
Adaptive biotechnologies chief commercial officer sells $32,265 in shares. - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 1,195 Shares - MarketBeat
Adaptive Biotechnologies (NASDAQ: ADPT) CCO sells shares under pre-set trading plan - Stock Titan
ADPT Looks 137.6% Overvalued on GF Value™ - gurufocus.com
Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ® - Yahoo Finance
Alert incorrectly tagged to Adaptive Biotechnologies withdrawn - marketscreener.com
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Adaptive Biotechnologies (ADPT) officer to sell 142K shares - Stock Titan
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 52-Week HighTime to Buy? - MarketBeat
A Look at Adaptive Biotechnologies Corp (ADPT) After 7.7% Gain -- GF Value $11.66 vs Price $26.68 - gurufocus.com
Officer at Adaptive Biotechnologies (NASDAQ: ADPT) plans sale of 1,195 shares - Stock Titan
Adaptive Biotechnologies stock hits 52-week high at 26.89 USD By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 6.4%What's Next? - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at 26.89 USD - Investing.com
Adaptive Biotechnologies Corp (ADPT) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Adaptive Biotechnologies (NASDAQ: ADPT) director reports stock gift, still holds 66,100 shares - Stock Titan
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - The Manila Times
Morgan Stanley’s healthcare conference sets a biotech chat for Sept. 15 - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Peer Comparison – Compare with Others - Value Research
Adaptive Biotechnologies Corp (ADPT) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Director Katey Owen Sells 9,615 Shares of Adaptive Biotechnologies Corp (ADPT) - GuruFocus
Adaptive Biotechnologies director Owen sells $249,990 in stock. By Investing.com - Investing.com India
Adaptive Biotechnologies director Owen sells $249,990 in stock. - Investing.com
Adaptive Biotechnologies stock hits 52-week high at $26.63 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at $26.63 - Investing.com
Adaptive Biotech (NASDAQ: ADPT) director lines up $249,990 stock sale - Stock Titan
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - inkl
Bank of America Corp DE Acquires 421,645 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares - Investing.com
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (NASDAQ:ADPT) Director Robert Hershberg Sells 30,664 Shares of Stock - MarketBeat
Adaptive Biotechnologies Director Robert Hershberg Executes Stock Option and Sells Shares - Kalkine Media
Adaptive Biotech (NASDAQ: ADPT) ex-officer to sell 402,160 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) director exercises option at $6.32 strike - Stock Titan
Adaptive Biotechnologies director Neupert sells $3.1m in stock By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares By Investing.com - Investing.com India
Adaptive Biotechnologies director Neupert sells $3.1m in stock - Investing.com
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) CEO Chad Robins Sells 278,676 Shares - MarketBeat
Adaptive Biotechnologies (ADPT) CEO sells 600K shares after exercising options - Stock Titan
0.45%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):